Again, through the chair, you're dealing with sensitive commercial issues. As an association representative, we don't have guidance, policies or best practices that direct how payers and companies deal with this, but understanding that this is a tension, I think if we were to get to a table, this is another point that could be discussed.
On June 4th, 2021. See this statement in context.